The GLP-1 boom has a dark side, although serious complications are rare – The Washington Post

  1. The GLP-1 boom has a dark side, although serious complications are rare The Washington Post
  2. Take Ozempic or Wegovy? The FDA says there’s a new warning you shouldn’t ignore Fast business
  3. FDA orders new eye risks listed on a dozen GLP-1s, including Novo’s Ozempic and Lilly’s Zepbound Fierce pharmaceutical
  4. Hopkins expert offers advice after FDA warning about GLP-1 and blindness The Baltimore Banner
  5. FDA issues new safety warning on GLP-1 drugs Page Med today

Gn bussni

Logo